IYH holdings
All 104 positions of iShares U.S. Healthcare ETF.
Positions
104
Top 10 weight
58.7%
Effective holdings
19.0
1 / sum of squared weights
In stocks
99.8%
In bonds
0.0%
Outside the US
0.1%
Asset mix
Sectors
100% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly & Co. | Equity | 14.83% | $609M | 520,659 | US |
| 2 | JNJJohnson & Johnson | Equity | 9.81% | $403M | 1,571,353 | US |
| 3 | ABBVABBVIE INC. | Equity | 7.66% | $315M | 1,154,578 | US |
| 4 | MRKMerck & Co., Inc. | Equity | 5.59% | $230M | 1,613,314 | US |
| 5 | UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | Equity | 5.32% | $218M | 588,891 | US |
| 6 | TMOThermo Fisher Scientific, Inc. | Equity | 3.85% | $158M | 242,421 | US |
| 7 | AMGNAmgen Inc | Equity | 3.49% | $143M | 351,987 | US |
| 8 | GILDGilead Sciences Inc | Equity | 2.90% | $119M | 810,169 | US |
| 9 | ABTAbbott Laboratories | Equity | 2.71% | $111M | 1,130,043 | US |
| 10 | PFEPfizer Inc. | Equity | 2.52% | $103M | 3,713,194 | US |
| 11 | ISRGIntuitive Surgical Inc. | Equity | 2.33% | $96M | 229,912 | US |
| 12 | DHRDanaher Corporation | Equity | 2.18% | $90M | 412,102 | US |
| 13 | VRTXVertex Pharmaceuticals Inc | Equity | 2.03% | $83M | 165,783 | US |
| 14 | BMYBristol-Myers Squibb Co. | Equity | 1.93% | $79M | 1,331,729 | US |
| 15 | MDTMedtronic plc | Equity | 1.79% | $73M | 836,433 | US |
| 16 | SYKStryker Corporation | Equity | 1.52% | $62M | 225,537 | US |
| 17 | ELVElevance Health, Inc. | Equity | 1.38% | $57M | 141,554 | US |
| 18 | REGNRegeneron Pharmaceuticals Inc | Equity | 1.17% | $48M | 64,722 | US |
| 19 | CIThe Cigna Group | Equity | 1.17% | $48M | 170,272 | US |
| 20 | MRNAModerna, Inc. Common Stock | Equity | 1.14% | $47M | 237,337 | US |
| 21 | HCAHCA Healthcare, Inc. | Equity | 1.03% | $42M | 95,052 | US |
| 22 | BSXBoston Scientific Corp. | Equity | 0.99% | $41M | 966,947 | US |
| 23 | NTRANatera, Inc. Common Stock | Equity | 0.85% | $35M | 89,088 | US |
| 24 | BDXBecton, Dickinson and Co. | Equity | 0.80% | $33M | 179,411 | US |
| 25 | EWEdwards Lifesciences Corp | Equity | 0.76% | $31M | 371,795 | US |
| 26 | AAgilent Technologies Inc. | Equity | 0.75% | $31M | 184,260 | US |
| 27 | HUMHumana Inc. | Equity | 0.74% | $30M | 78,290 | US |
| 28 | VEEVVeeva Systems Inc. | Equity | 0.68% | $28M | 97,349 | US |
| 29 | IQVIQVIA Holdings Inc. | Equity | 0.67% | $28M | 106,424 | US |
| 30 | WATWaters Corp | Equity | 0.67% | $28M | 64,094 | US |
| 31 | IDXXIdexx Laboratories Inc | Equity | 0.64% | $26M | 51,584 | US |
| 32 | ILMNIllumina Inc | Equity | 0.64% | $26M | 99,117 | US |
| 33 | RVMDRevolution Medicines, Inc. Common Stock | Equity | 0.57% | $23M | 124,860 | US |
| 34 | RMDResMed Inc. | Equity | 0.52% | $21M | 94,684 | US |
| 35 | BIIBBiogen Inc. Common Stock | Equity | 0.51% | $21M | 96,018 | US |
| 36 | CNCCentene Corporation | Equity | 0.51% | $21M | 321,444 | US |
| 37 | DXCMDexCom, Inc. | Equity | 0.50% | $21M | 244,647 | US |
| 38 | ZTSZOETIS INC. | Equity | 0.49% | $20M | 274,221 | US |
| 39 | ALNYAlnylam Pharmaceuticals, Inc. | Equity | 0.48% | $20M | 86,994 | US |
| 40 | GEHCGE HealthCare Technologies Inc. Common Stock | Equity | 0.46% | $19M | 295,943 | US |
| 41 | LHLabcorp Holdings Inc. | Equity | 0.41% | $17M | 53,529 | US |
| 42 | DGXQuest Diagnostics Inc. | Equity | 0.41% | $17M | 72,067 | US |
| 43 | WSTWest Pharmaceutical Services, Inc. | Equity | 0.40% | $17M | 45,588 | US |
| 44 | RPRXRoyalty Pharma plc Class A Ordinary Shares | Equity | 0.37% | $15M | 270,200 | US |
| 45 | UTHRUnited Therapeutics Corp | Equity | 0.35% | $14M | 26,986 | US |
| 46 | INSMInsmed, Inc. | Equity | 0.34% | $14M | 139,778 | US |
| 47 | GHGuardant Health, Inc. Common Stock | Equity | 0.34% | $14M | 84,048 | US |
| 48 | THCTenet Healthcare Corporation New | Equity | 0.33% | $14M | 52,081 | US |
| 49 | STESTERIS plc | Equity | 0.33% | $13M | 63,759 | US |
| 50 | VTRSViatris Inc. Common Stock | Equity | 0.32% | $13M | 757,013 | US |
| 51 | INCYIncyte Genomics Inc | Equity | 0.30% | $12M | 109,649 | US |
| 52 | ROIVRoivant Sciences Ltd. Common Shares | Equity | 0.28% | $11M | 335,785 | US |
| 53 | ZBHZimmer Biomet Holdings, Inc. | Equity | 0.27% | $11M | 126,136 | US |
| 54 | RVTYRevvity, Inc. | Equity | 0.27% | $11M | 72,747 | US |
| 55 | MDLNMedline Inc. Class A common stock | Equity | 0.25% | $10M | 292,121 | US |
| 56 | EXELExelixis Inc | Equity | 0.23% | $9.5M | 160,857 | US |
| 57 | CRLCharles River Laboratories International, Inc. | Equity | 0.23% | $9.3M | 31,216 | US |
| 58 | NBIXNeurocrine Biosciences Inc | Equity | 0.22% | $9.1M | 64,563 | US |
| 59 | MEDPMedpace Holdings, Inc. Common Stock | Equity | 0.22% | $8.9M | 14,726 | US |
| 60 | JAZZJazz Pharmaceuticals, Inc. | Equity | 0.21% | $8.7M | 38,951 | US |
| 61 | HALOHalozyme Therapeutics, Inc. | Equity | 0.20% | $8.4M | 76,502 | US |
| 62 | SOLVSolventum Corporation | Equity | 0.20% | $8.3M | 96,315 | US |
| 63 | BAXBaxter International Inc. | Equity | 0.20% | $8.0M | 335,884 | US |
| 64 | PENPenumbra, Inc. | Equity | 0.19% | $7.9M | 24,783 | US |
| 65 | EHCEncompass Health Corporation Common Stock | Equity | 0.19% | $7.8M | 64,039 | US |
| 66 | ASNDAscendis Pharma A/S Ordinary Share | Equity | 0.19% | $7.7M | 34,666 | US |
| 67 | TECHBio-Techne Corp. | Equity | 0.18% | $7.4M | 101,882 | US |
| 68 | CORTCorcept Therapeutics Inc. | Equity | 0.18% | $7.3M | 61,703 | US |
| 69 | ELANElanco Animal Health Incorporated Common Stock | Equity | 0.18% | $7.3M | 322,238 | US |
| 70 | BBIOBridgeBio Pharma, Inc. Common Stock | Equity | 0.17% | $7.2M | 110,105 | US |
| 71 | COOThe Cooper Companies, Inc. Common Stock | Equity | 0.17% | $6.9M | 127,176 | US |
| 72 | BMRNBioMarin Pharmaceuticals Inc | Equity | 0.17% | $6.9M | 124,944 | US |
| 73 | AVTRAvantor, Inc. | Equity | 0.16% | $6.6M | 430,926 | US |
| 74 | MOHMolina Healthcare, Inc. | Equity | 0.16% | $6.6M | 33,539 | US |
| 75 | ENSGThe Ensign Group, Inc. | Equity | 0.15% | $6.3M | 36,855 | US |
| 76 | RGENRepligen Corp | Equity | 0.15% | $6.3M | 38,535 | US |
| 77 | ALGNAlign Technology Inc | Equity | 0.15% | $6.2M | 43,660 | US |
| 78 | PODDInsulet Corporation | Equity | 0.15% | $6.1M | 45,093 | US |
| 79 | QGENQIAGEN N.V. | Equity | 0.15% | $6.0M | 134,012 | DE |
| 80 | UHSUniversal Health Services, Inc. Class B | Equity | 0.14% | $5.8M | 33,245 | US |
| 81 | MDGLMadrigal Pharmaceuticals, Inc. Common Stock | Equity | 0.14% | $5.6M | 11,650 | US |
| 82 | HSICHenry Schein Inc | Equity | 0.13% | $5.4M | 64,126 | US |
| 83 | GMEDGLOBUS MEDICAL INC | Equity | 0.13% | $5.4M | 73,333 | US |
| 84 | ARWRArrowhead Research Corporation | Equity | 0.13% | $5.3M | 88,006 | US |
| 85 | TEMTempus AI, Inc. Class A Common Stock | Equity | 0.12% | $4.8M | 69,923 | US |
| 86 | XTSLABLK CSH FND TREASURY SL AGENCY | Cash | 0.12% | $4.8M | 4,830,802 | US |
| 87 | AXSMAxsome Therapeutics, Inc | Equity | 0.12% | $4.8M | 28,039 | US |
| 88 | IONSIonis Pharmaceuticals, Inc. Common Stock | Equity | 0.11% | $4.6M | 107,247 | US |
| 89 | BIOBio-Rad Laboratories, Inc.Class A | Equity | 0.10% | $4.2M | 11,780 | US |
| 90 | BRKRBruker Corporation | Equity | 0.10% | $4.2M | 72,159 | US |
| 91 | CHEChemed Corporation | Equity | 0.10% | $4.2M | 8,338 | US |
| 92 | DVADaVita Inc. | Equity | 0.10% | $3.9M | 22,308 | US |
| 93 | TFXTeleflex Incorporated | Equity | 0.09% | $3.6M | 28,859 | US |
| 94 | SHCSotera Health Company Common Stock | Equity | 0.08% | $3.3M | 183,231 | US |
| 95 | DOCSDoximity, Inc. | Equity | 0.06% | $2.4M | 81,758 | US |
| 96 | NVSTEnvista Holdings Corporation Common stock, $0.01 par value per share | Equity | 0.06% | $2.4M | 105,528 | US |
| 97 | OGNOrganon & Co. | Equity | 0.06% | $2.3M | 169,841 | US |
| 98 | CAICaris Life Sciences, Inc. Common Stock | Equity | 0.05% | $2.2M | 80,244 | US |
| 99 | VKTXViking Therapeutics, Inc | Equity | 0.05% | $2.0M | 73,782 | US |
| 100 | SMMTSummit Therapeutics Inc. Common Stock | Equity | 0.04% | $1.6M | 90,492 | US |
| 101 | USDProShares Ultra Semiconductors | Cash | 0.03% | $1.3M | 1,331,135 | US |
| 102 | WFFUTCASH COLLATERAL USD WFFUT | Cash | 0.01% | $394K | 393,999 | US |
| 103 | HOLXHologic Inc | Equity | 0.00% | $1K | 117,311 | US |
| 104 | IXCZ6E-MINI HEALTH CARE SECTOR DEC 26 | Derivative | 0.00% | $0 | 41 |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Exit | EXASEXACT SCIENCES CORPORATION | 0.33% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | MDLNMEDLINE INC. | — | 0.26% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | WATWATERS CORPORATION | 0.38% | 0.56% | +65.0% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | CAICARIS LIFE SCIENCES, INC. | 0.01% | 0.03% | +307.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | SHCSOTERA HEALTH COMPANY | 0.06% | 0.07% | +19.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.